Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × regorafenib × Clear all

Phase

Status

Completed 12 Unknown 2 Terminated 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 10 Carcinoma, Hepatocellular 6 Rectal Neoplasms 2 Liver Neoplasms 2 Glioblastoma 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Meningioma 1 Melanoma 1 MCRC 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Metastases 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Neoplasms 1

Interventions

pembrolizumab 43 Specimen Handling 28 Magnetic Resonance Spectroscopy 24 Biopsy 24 Radiosurgery 17 Gemcitabine 14 Nivolumab 12 Cisplatin 11 Paclitaxel 10 Cyclophosphamide 10 Carboplatin 10 Capecitabine 9 Taxes 8 Pemetrexed 8 Leucovorin 8 Irinotecan 8 Fluorouracil 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Oxaliplatin 7 Drug Therapy 7 Doxorubicin 7 olaparib 6 cemiplimab 6 abemaciclib 6 Radiotherapy 6 Folfox protocol 6 Docetaxel 6 ribociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116541 2025-11-21

MegaMOST

Centre Leon Berard

Phase 2 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡